Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
OnKure Therapeutics, Inc.OnKure Therapeutics Reports $31.3 Million Net Loss for First Half of 2025
CARPENTER TECHNOLOGY CORPCarpenter Technology Reports 4% Revenue Growth to $2.877 Billion for Fiscal Year Ending June 30, 2025
Madison Square Garden Sports Corp.Madison Square Garden Sports Reports 1% Revenue Increase but Posts $22.4 Million Net Loss
PROKIDNEY CORP.ProKidney Reports $221,000 Revenue in Q2 2025, Continues to Operate at a Loss
Intellicheck, Inc.Intellicheck Reports 10% Revenue Growth in Q2 2025, Net Loss Increases
Pulse Biosciences, Inc.Pulse Biosciences Reports $19.2 Million Net Loss and No Revenue in Latest Quarter
Nkarta, Inc.Nkarta Reports Q2 2025 Financial Results with Reduced Net Loss and Increased Cash Reserves
TRAVELZOOTravelzoo Reports 13% Revenue Growth to $23.9 Million in Q2 2025
Global Gas CorpGlobal Gas Corporation Reports First Revenue Recognition and Decrease in Net Income for Q2 2025
DiaMedica Therapeutics Inc.DiaMedica Therapeutics Reports $7.7 Million Net Loss in Q2 2025
WILLAMETTE VALLEY VINEYARDS INCWillamette Valley Vineyards Reports Decline in Revenue and Profitability for Q2 and First Half of 2025
INTELLIGENT PROTECTION MANAGEMENT CORP.Intelligent Protection Management Corp. Reports 2,008.5% Revenue Growth to $5.7 Million in Q2 2025
PSQ Holdings, Inc.PSQ Holdings Reports 18% Revenue Growth in Q2 2025 Despite Net Loss
Fold Holdings, Inc.Fold Holdings Reports 59% Revenue Growth to $8.2 Million in Q2 2025
VOC Energy TrustVOC Energy Trust Reports Decline in Revenue and Profitability for Q2 and First Half of 2025
Rekor Systems, Inc.Rekor Systems Reports Revenue Decline and Improved Net Loss in Q2 2025
Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics Reports 96% Revenue Increase in Q2 2025 Amid Rising Losses
Stoke Therapeutics, Inc.Stoke Therapeutics Reports $13.8M Revenue and $23.5M Net Loss for Q2 2025
Constellation Acquisition Corp IConstellation Acquisition Corp I Reports Net Loss of $220,858 for Quarter Ending June 30, 2025
Generation Bio Co.Generation Bio Reports 81% Decline in Collaboration Revenue and $20.9 Million Net Loss in Q2 2025
CalciMedica, Inc.CalciMedica Reports Increased Net Loss of $10.998 Million for First Half of 2025
Rocket One Inc.Hoth Therapeutics Reports $2.2 Million Net Loss in Q2 2025, Increases R&D Spending
MV Oil TrustMV Oil Trust Reports Significant Decline in Financial Performance for Q2 2025
STANDARD PREMIUM FINANCE HOLDINGS, INC.Standard Premium Finance Reports Q2 2025 Results with Revenue Decline and Net Income Increase
Lyell Immunopharma, Inc.Lyell Immunopharma Reports $42.7 Million Net Loss in Q2 2025, Revenue Declines